Fitell Corporation (NASDAQ: FTEL) ('Fitell” or the 'Company”) announced today the appointment of Jack Zeng as the Head of ...

This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to ...